| Number of Patients |
---|---|
Breath control techniques | |
 Gating | 20 |
 Active breathing control | 7 |
 Free Breathing | 4 |
Prescriptions | |
 5–7.5 GyE X 8–10 Fx | 12 |
 4–5 GyE X 15–16 Fx | 3 |
 2.25–3.5 GyE X 22–31 Fx | 16 |
BED10 (GyE), median (range) | 96 (75–119) |
Radiation techniques/sources | |
 PRT only | 6 |
 PRT + CIRT boost | 6 |
 CIRT only | 19a |
Chemotherapy | 6 |
 1 cycle (neoadjuvant of pemetrexed+ cisplatin) | 1 |
 3 cycles (concurrent of Taxol+ cisplatin) | 1 |
 4 cycles (neoadjuvant of etoposide+ cisplatin) | 1 |
 4 cycles (neoadjuvant of pemetrexed X 3+ docetaxel X 1) | 1 |
 5 cycles (neoadjuvant of gemcitabine+ cisplatin X 3 + concurrent of Taxol+ cisplatin X 2) | 1 |
 6 cycles (neoadjuvant of gemcitabine+ cisplatin) | 1 |